https://biotechmorning.com/news/caribou-biosciences-off-the-shelf-car-t-data Biotech Morning en 2026-06-11T14:25:02.844Z The $2 Stock Trying to Kill the $500K Cancer Treatment https://biotechmorning.com/news/ethyreal-bio-101m-tepezza-thyroid-eye-disease Biotech Morning en 2026-06-11T14:24:03.541Z The $101M Startup That Wants to Kill Tepezza's Monopoly at the Root https://biotechmorning.com/news/astrazeneca-oral-glp1-obesity-pill-phase-3 Biotech Morning en 2026-06-11T14:23:08.168Z AstraZeneca Just Bet Billions It Can Win the Obesity Pill Wars https://biotechmorning.com/news/parabilis-670m-record-biotech-ipo Biotech Morning en 2026-06-11T14:22:08.254Z The $670M Debut That Just Broke Biotech's All-Time Record https://biotechmorning.com/news/glp1-drugs-gut-microbe-depression Biotech Morning en 2026-06-11T14:21:13.503Z Your Ozempic Might Be Growing a Tiny Therapist in Your Gut https://biotechmorning.com/news/enliven-therapeutics-cml-leukemia-data Biotech Morning en 2026-06-11T14:20:21.272Z The Tiny Biotech That Might Dethrone Novartis in Leukemia https://biotechmorning.com/news/sonothera-125m-series-b-ultrasound-gene-therapy Biotech Morning en 2026-06-11T14:19:23.061Z This Startup Wants to Blast Genes Into Your Cells With Sound Waves https://biotechmorning.com/news/novo-nordisk-cagrisema-retatrutide-ada-2026 Biotech Morning en 2026-06-11T14:18:27.130Z Novo Nordisk's Top Scientist Just Said the Quiet Part Out Loud https://biotechmorning.com/news/sanofi-plan-b-lost-its-plan-b Biotech Morning en 2026-06-11T14:17:34.746Z Sanofi's Plan B Just Lost Its Plan B https://biotechmorning.com/news/takeda-zasocitinib-beats-sotyktu-psoriasis Biotech Morning en 2026-06-11T14:16:37.869Z The $4 Billion Pill That Just Embarrassed Bristol Myers https://biotechmorning.com/news/glp1-drugs-cancer-risk-reduction-asco-2026 Biotech Morning en 2026-06-10T14:27:45.218Z Ozempic Might Fight Cancer. ASCO Just Dropped the Receipts. https://biotechmorning.com/news/gilead-trodelvy-nsclc-lung-cancer-failure Biotech Morning en 2026-06-10T14:26:54.780Z Gilead Spent $21 Billion on a Drug That Can't Crack Lung Cancer https://biotechmorning.com/news/daraxonrasib-ras-cancer-survival-breakthrough Biotech Morning en 2026-06-10T14:25:54.273Z The Cancer Target That Stumped Scientists for 40 Years Just Got Cracked Wide Open https://biotechmorning.com/news/lilly-haisco-3-billion-china-deal Biotech Morning en 2026-06-10T14:25:03.649Z Lilly Just Wrote a $3 Billion Check to a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years Biotech Morning en 2026-06-10T14:24:06.633Z America's Sunscreen Has Been Stuck in 1999. That Just Changed. https://biotechmorning.com/news/japan-approves-telomelysin-cancer-killing-virus Biotech Morning en 2026-06-10T14:23:11.723Z Japan Just Approved a Cancer-Killing Virus. Yes, You Read That Right. https://biotechmorning.com/news/novartis-orionis-molecular-glue-deal Biotech Morning en 2026-06-10T14:22:20.234Z Why Novartis Keeps Writing Billion-Dollar Checks to This Biotech https://biotechmorning.com/news/fda-meeting-killed-fulcrum-therapeutics Biotech Morning en 2026-06-10T14:21:21.214Z One FDA Meeting Killed This Entire Biotech Company https://biotechmorning.com/news/bepirovirsen-hepatitis-b-functional-cure-phase-3 Biotech Morning en 2026-06-10T14:20:19.461Z The 6-Month Shot That Could Let Millions Ditch Daily Hep B Pills https://biotechmorning.com/news/pentagon-blacklist-wuxi-apptec-biotech-supplier Biotech Morning en 2026-06-10T14:19:18.624Z The Pentagon Just Dropped a Bomb on Biotech's Favorite Supplier https://biotechmorning.com/news/ivonescimab-beats-pd1-inhibitor-overall-survival-squamous-nsclc Biotech Morning en 2026-06-10T14:18:17.152Z The Two-in-One Cancer Drug That Just Beat the Gold Standard